← All indications
Postpartum Hemorrhage
Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).
Drugs by status
Approved for this indication (5)
Phase 4 trials (19)
Phase 3 trials (3)
Phase 2 trials (3)
Phase 1 trials (4)
Organizations
Organization Involved with Phase 4 Indications (48)
- Gynuity Health Projects
- Laboratoire français de Fractionnement et de Biotechnologies
- National Institutes of Health (NIH)
- United States Navy
- Bakirkoy Dr. Sadi Konuk Research and Training Hospital
- Ain Shams University
- Alexandria University
- Cairo University
- Cedars-Sinai Medical Center
- Centre Hospitalier Universitaire de Nīmes
- Harvard University
- Erzincan University
- Ghamra Military Hospital
- Hédi Chaker Hospital
- Loyola University
- New York University
- Talkha Central Hospital
- Universidad Autonoma de Nuevo Leon
- University of Malaya
- University of Saskatchewan
- University of Athens
- University of Zurich
- Assiut University
- Laval University
- University of California, San Francisco
- University of Baghdad
- Jiao Tong University
- Beni Suef University
- Lutheran Medical Center
- National University of Singapore
- +18 more
Organization Involved with Phase 3 Indications (49)
- AstraZeneca
- Cipla
- Pharmacosmos
- Azienda U.S.L. 1 di Massa e Carrara
- Ministry of Health, Malaysia
- Rabin Medical Center
- University of Pittsburgh
- University of London
- Gloucestershire Hospitals NHS Foundation Trust
- Institut National de la Santé Et de la Recherche Médicale, France
- Jawaharlal Nehru Medical College
- KK Women's and Children's Hospital
- Makerere University
- Mansoura University
- Mbarara University of Science and Technology
- Saint Thomas Hospital, Panama
- Stanford University
- University of The West Indies
- University of Liverpool
- University of Toronto
- University of Bath
- University of Bordeaux
- University of Bristol
- University of Waterloo
- University of Zimbabwe
- Aga Khan University
- Tel Aviv University
- University of Copenhagen
- Sinai Health System
- University of Angers
- +19 more
Organization Involved with Phase 2 Indications (7)
Organization Involved with Phase 1 Indications (10)
Organization Involved with Other Experimental Indications (59)
- Jhpiego
- National Cancer Institute (NCI)
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Dr. D. Y. Patil Dental College & Hospital
- Benha University
- Etlik Zubeyde Hanim Womens' Health and Teaching Hospital
- Guangzhou Medical University
- Hacettepe University
- Makassed General Hospital
- National University of Malaysia
- New York City Health and Hospitals Corporation
- RTI International
- Thomas Jefferson University
- University of Pretoria
- Kanuni Sultan Suleyman Training and Research Hospital
- Sohag University
- University of British Columbia
- University of Cape Town
- Vanderbilt University
- Icahn School of Medicine at Mount Sinai
- Bagcilar Research and Training Hospital
- University of the Witwatersrand
- University of Missouri
- Southern Medical University
- Guangzhou University
- University of Ljubljana
- Sivas State Hospital
- Zekai Tahir Burak Hospital
- Sun Yat-Sen University
- +29 more